Detalles de la búsqueda
1.
Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Br J Haematol
; 196(3): 589-598, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34632572
2.
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis.
Ann Rheum Dis
; 81(4): 524-536, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35045965
3.
Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Hematol Oncol
; 39 Suppl 1: 83-87, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105816
4.
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens.
Haematologica
; 105(4): 1032-1041, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31296574
5.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.
J Immunol
; 200(8): 2581-2591, 2018 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531171
6.
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.
Int J Cancer
; 144(11): 2762-2773, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30468254
7.
Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas.
Br J Haematol
; 184(3): 373-383, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30565652
8.
Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.
Haematologica
; 104(4): 778-788, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29954928
9.
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Haematologica
; 107(12): 2990, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453521
10.
The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling.
Haematologica
; 102(10): 1776-1784, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28751557
11.
Interleukin-1 receptor associated kinase 1/4 and bromodomain and extra-terminal inhibitions converge on NF-κB blockade and display synergistic antitumoral activity in activated B-cell subset of diffuse large B-cell lymphoma with MYD88 L265P mutation.
Haematologica
; 106(10): 2749-2753, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979991
12.
SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
Blood
; 121(12): 2175-85, 2013 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23321250
13.
A cyclization-rearrangement cascade for the synthesis of structurally complex chiral gold(I)-aminocarbene complexes.
Angew Chem Int Ed Engl
; 53(31): 8122-6, 2014 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25044294
14.
Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target.
Blood Cancer J
; 14(1): 75, 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697976
15.
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.
Blood
; 117(1): 26-38, 2011 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20940415
16.
The Hsp90 inhibitor IPI-504 overcomes bortezomib resistance in mantle cell lymphoma in vitro and in vivo by down-regulation of the prosurvival ER chaperone BiP/Grp78.
Blood
; 117(4): 1270-9, 2011 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-21106982
17.
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
Blood
; 117(2): 563-74, 2011 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20940416
18.
Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.
Blood
; 117(2): 542-52, 2011 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20956803
19.
The phosphatidylinositol-3-kinase inhibitor NVP-BKM120 overcomes resistance signals derived from microenvironment by regulating the Akt/FoxO3a/Bim axis in chronic lymphocytic leukemia cells.
Haematologica
; 98(11): 1739-47, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23850807
20.
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36854569